Crispr Therapeutics gets European gene-editing patent – The Boston Globe
The Boston Globe |
Crispr Therapeutics gets European gene-editing patent
The Boston Globe Crispr Therapeutics Inc., a Swiss-based biotech with its main research lab in Cambridge, said Tuesday that it has won a broad patent in Europe for gene-editing technology licensed from the University of California in Berkeley and the University of Vienna. CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing European Patent Office to Grant Broad Claims on Patent Covering … |
